The Safety and Effectiveness of 524W91

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Emtricitabine

Trial Locations (1)

94103

ViRx Inc, San Francisco

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Glaxo Wellcome

INDUSTRY

NCT00002335 - The Safety and Effectiveness of 524W91 | Biotech Hunter | Biotech Hunter